A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 601–700 of 1,000
Restriction fragment length polymorphism of the human c-fms gene.
Xu, D. Q., Guilhot, S., & Galibert, F. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.2862 · Cited by 25
Chronic Myeloid Leukemia: Current Perspectives
Zhang, Y., & Rowley, J. D. (2011) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2011.08.012 · Cited by 24
Zhao, Z.-G., Li, W., Chen, Z., You, Y., & Zou, P. (2008) · Immunological Investigations · doi:10.1080/08820130802349940 · Cited by 24
“Chronic myeloid leukemia (CML) results from the oncogenic transformation of hematopoietic stem cells by the BCR-ABL fusion gene generated by the t(9;22)(q34;q11) translocation that produces the Philadelphia chromosome (de Klein et al., 1982; Rowley, 1973).”
BackgroundAbl N-Terminal Cap Stabilization of SH3 Domain Dynamics
Chen, S., Dumitrescu, T. P., Smithgall, T. E., & Engen, J. R. (2008) · Biochemistry · doi:10.1021/bi800446b · Cited by 24
Kircher, B., Schumacher, P., Petzer, A., Hoflehner, E., Haun, M., Wolf, A. M., Nachbaur, D., & Gastl, G. A. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01242.x · Cited by 24
“Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by t(9;22) translocation resulting in a chimeric P210 bcr ⁄ abl protein with altered tyrosine kinase activity (1, 2).”
BackgroundBlakes, A. J. M., Gaul, E., Lam, W. W. K., Shannon, N. L., Knapp, K. M., Bicknell, L. S., Jackson, M. R., Wade, E. M., Robertson, S. P., White, S. M., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00766-w · Cited by 24
Rasheed, S. (1995) · Springer eBooks · doi:10.1007/978-1-4899-1721-8_5 · Cited by 25
Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase
Reddy, M. V. R., Pallela, V. R., Cosenza, S. C., Mallireddigari, M. R., Patti, R., Bonagura, M., Truongcao, M. M., Akula, B., Jatiani, S., & Reddy, E. P. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.051 · Cited by 24
The Role of Autologous Natural Killer Cells in Chronic Myelogenous Leukemia
Pierson, B. A., & Miller, J. S. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709058306 · Cited by 24
Applications and Limitations of Polymerase Chain Reaction Amplification
Tony, S. (1995) · CHEST Journal · doi:10.1378/chest.108.5.1393 · Cited by 27
Silver, R. T. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00088-1 · Cited by 30
Isidoro‐García, M., Tabernero, M. D., Garcı́a, J. L., Najera, M. L., Hernández‐Rivas, J. M., Wiegant, J. C. A. G., Raap, A. K., Miguel, J. F. S., & Órfão, A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90099-x · Cited by 24
Imaizumi, M., Uozumi, J., & Breitman, T. R. (1987) · PubMed · Cited by 24
A neuroendocrine tumor of the small intestine with a karyotype of 46,XY,t(11;22)
Vigfusson, N. V., Allen, L., Phillips, J. H., Alschibaja, T., & Riches, W. G. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90157-3 · Cited by 24
Translocations in T-Cell Leukemia and Lymphoma
Hecht, F., Morgan, R., Gemmill, R. M., & Hecht, B. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131218 · Cited by 24
Preferentially expressed genes in chronic myelogenous leukemia
Mars, W., Florine, D., Talpaz, M., & Saunders, G. (1985) · Blood · doi:10.1182/blood.v65.5.1218.1218 · Cited by 24
Silver, R. T., & Gale, R. P. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90676-5 · Cited by 24
Quantification of Fewer than Ten Copies of a DNA Biomarker without Amplification or Labeling
Lee, Y., Kim, Y., Lee, D. G., Roy, D., & Park, J. W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02791 · Cited by 23
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker
Xiao, L., Lanz, R. B., Frolov, A., Castro, P. D., Zhang, Z., Dong, B., Xue, W., Jung, S. Y., Lydon, J. P., Edwards, D. P., et al. (2016) · The Prostate · doi:10.1002/pros.23213 · Cited by 26
“It produces the bcr/abl fusion gene, leading to the expression of a constitutively active protein tyrosine kinase [2].”
BackgroundAn accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia
Raponi, S., Propris, M. S. D., Wai, H., Intoppa, S., Elia, L., Diverio, D., Vitale, A., Foà, R., & Guarini, A. R. (2009) · Haematologica · doi:10.3324/haematol.2009.010900 · Cited by 23
“The Ph chromosome is created through the translocation of a section of human chromosome 9 that contains the Abelson (ABL) kinase domain, with a specific breakpoint cluster region (BCR) on chromosome 22.(6,7) The resulting fusion gene BCR-ABL encodes for an abnormal, non-membrane-bound oncoprotein.”
BackgroundDNAdetection of chronic myelogenous leukemia by magnetic nanoparticles
Jangpatarapongsa, K., Polpanich, D., Yamkamon, V., Dittharot, Y., Pengon, J., Thiramanas, R., Hongeng, S., Jootar, S., Charoenmak, L., & Tangboriboonrat, P. (2010) · The Analyst · doi:10.1039/c0an00374c · Cited by 23
Hummel, J. M., Kletecka, M. C. F., Sanks, J., Chiselite, M. D., Roulston, D., Smith, L. B., Czuchlewski, D. R., Elenitoba‐Johnson, K. S. J., & Lim, M. S. (2012) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e318246975e · Cited by 24
Bhatia, R., Williams, A. D., & Munthe, H. A. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00799-8 · Cited by 24
Mundhada, S. G., Luthra, R., & Cano, P. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-25 · Cited by 23
Tena‐Sempere, M., Kero, J. T., Rannikko, A. S., Yan, W., & Huhtaniemi, I. T. (1999) · Endocrinology · doi:10.1210/endo.140.12.7193 · Cited by 23
Ikeguchi, A. P., Yang, H.-Y., Gao, G., & Goff, S. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204502 · Cited by 23
“In addition, nearly all cases of chronic myelogenous leukemia (CML) in humans are initiated by chromosomal translocation that fuses the BCR and ABL genes to produce an activated BCR-ABL kinase (de Klein et al., 1982).”
BackgroundThe Involvement of Oncogenes and Suppressor Genes in Human Neoplasia
Brodeur, G. M. (1987) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00153-1 · Cited by 23
Unusual Ph translocations in CML: Four new cases
Sessarego, M., Ajmar, F., Bianchi‐Scarrà, G., Ravazzolo, R., Garrè, C., & Boccaccio, P. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90163-3 · Cited by 23
Inokuchi, K., Futaki, M., Yamada, T., Tanabe, Y., Dan, K., Shinohara, T., Kuriya, S., & Nomura, T. (1991) · Leukemia Research · doi:10.1016/0145-2126(91)90113-8 · Cited by 23
Regional localization of mouse Abl and Mos proto-oncogenes by in situ hybridization
Threadgill, D. W., & Womack, J. E. (1988) · Genomics · doi:10.1016/0888-7543(88)90164-4 · Cited by 23
Inokuchi, K., Wakita, S., Hirakawa, T., Tamai, H., Yokose, N., Yamaguchi, H., & Dan, K. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0910-z · Cited by 22
Miyazaki, K., Yamasaki, N., Oda, H., Kuwata, T., Kanno, Y., Miyazaki, M., Komeno, Y., Kitaura, J., Honda, Z.-I., Warming, S., et al. (2009) · Blood · doi:10.1182/blood-2007-05-088724 · Cited by 22
Detection and quantification of the Bcr/Abl chimeric protein on biochips using LDI-TOF MS
Hong, S., Kim, J. I., Kang, H., Yoon, S., Kim, D., Jung, W., & Yeo, W. (2014) · Chemical Communications · doi:10.1039/c4cc01332h · Cited by 22
Lam, Q., Lo, C. K. C., Zheng, B.-J., Ko, K., Osmond, D. G., Wu, G. E., Rottapel, R. K., & Lu, L. (2007) · International Immunology · doi:10.1093/intimm/dxl143 · Cited by 22
Philadelphia-positive leukemia: a personal perspective
Heisterkamp, N., & Groffen, J. (2002) · Oncogene · doi:10.1038/sj.onc.1206080 · Cited by 22
“1206080 Keywords: BCR/ABL; leukemia; BCR; ABL; Crkl; somatic cell hybrids History of the molecular genetics of the Ph-chromosome It was 20 years ago that de Klein et al. (1982) heralded the first chapter of the story of the molecular basis of the Ph-chromosome.”
BackgroundSelf-citationPatel, H., Marley, S. B., & Gordon, M. Y. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20377 · Cited by 22
HLA class II allele and haplotype frequencies in Iranian patients with leukemia.
Khosravi, F., Amirzargar, A., Sarafnejad, A., Nicknam, M. H., Alimoghadam, K., Dianat, S., Solgi, G., & Nikbin, B. (2007) · PubMed · Cited by 22
Nie, D., Huang, K., Yin, S., Li, Y., Xie, S., Ma, L., Wang, X., Wu, Y., Xiao, J., Wang, J., et al. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0049-2 · Cited by 22
Chang, W., Fujimiya, Y., Casteel, N., & Pattengale, P. K. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430410 · Cited by 22
Chiao, P. J., Bischoff, F. Z., Strong, L. C., & Tainsky, M. A. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00047589 · Cited by 25
Involvement of chromosome 9 in variant Ph1 translocation
Bartram, C. R., Anger, B., Carbonell, F., & Kleihauer, E. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90103-1 · Cited by 22
Self-citationArwert, F., Porck, H. J., Fr�ter-Schr�der, M., Brahe, C., van Kessel, A. G., Westerveld, A., Khan, P. M., Zang, K. D., Frants, R. R., Kortbeek, H. T., et al. (1986) · Human Genetics · doi:10.1007/bf00280489 · Cited by 22
Self-citationThe gene encoding the human preproacrosin (ACR) maps to the q13-qter region on chromosome 22
Adham, I. M., Grzeschik, K., van Kessel, A. H. M. G., & Engel, W. (1989) · Human Genetics · doi:10.1007/bf00210672 · Cited by 22
Self-citationKissil, J. L., & Kimchi, A. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01263-5 · Cited by 22
BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome
Mohamed, A. N., Koppitch, F. C., Varterasian, M. L., Karanes, C., Yao, K., & Sarkar, F. H. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130210 · Cited by 22
The detection of minimal residual disease in acute lymphoblastic leukaemia
Potter, M. N. (1992) · Blood Reviews · doi:10.1016/0268-960x(92)90009-f · Cited by 22
Bartram, C. R., Bross-Bach, U., Schmidt, H., & Waller, H. D. (1987) · Annals of Hematology · doi:10.1007/bf00320220 · Cited by 22
Self-citationThe Cytogenetics of Childhood Leukemia: Clinical and Biologic Implications
Look, A. T. (1988) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36507-5 · Cited by 22
Δ-PCR, A Simple Method to Detect Translocations and Insertion/Deletion Mutations
Lin, M., Tseng, L., Rich, R. G., Hafez, M. J., Harada, S., Murphy, K. M., Eshleman, J. R., & Gocke, C. D. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.004 · Cited by 21
From karyotypes to precision genomics in 9p deletion and duplication syndromes
Sams, E. I., Ng, J. K., Tate, V., Hou, Y. C., Cao, Y., Fulton, L., Belhassan, K., Neidich, J., Mitra, R. D., Cole, F. S., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100081 · Cited by 29
Clinical peptide vaccination trials for leukemia patients
Casalegno‐Garduño, R., Schmitt, A., & Schmitt, M. W. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.56 · Cited by 21
Wang, C., Bai, X., Wang, R., Zheng, X., Ma, X., Chen, H., Ai, Y., Bai, Y., & Liu, Y. (2019) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00227 · Cited by 21
Rosas-Cabral, A., Martínez-Mancilla, M., Ayala‐Sánchez, M., Vela‐Ojeda, J., Bahena-Reséndiz, P., Vadillo-Buenfil, M., Aviña-Zubieta, J. A., Salazar-Exaire, D., Miranda-Peralta, E., Marroquín, A., et al. (2003) · PubMed · Cited by 21
Genesis of variant philadelphia chromosome translocations in chronic myelocytic leukemia
Naumann, S., & Decker, H.-J. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00128-6 · Cited by 21
Landstrom, A. P., Ketterling, R. P., Knudson, R. A., & Tefferi, A. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600783551 · Cited by 21
Grignani, F. (1985) · PubMed · Cited by 21
Application of bone marrow transplantation in chronic granulocytic leukaemia
Goldman, J. M., & Baughan, A. S. J. (1983) · Clinics in Haematology · doi:10.1016/s0308-2261(83)80008-3 · Cited by 21
Ramakrishnan, L., & Rosenberg, N. E. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90043-7 · Cited by 22
Chronic Myelogenous Leukemia as a Model for the Genetic Basis of Cancer
Cannistra, S. A. (1990) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30491-x · Cited by 21
Terminal-Phase Chronic Myelogenous Leukemia: Approaches to Treatment
Allen, S. L., & Coleman, M. (1985) · Cancer Investigation · doi:10.3109/07357908509039811 · Cited by 21
Etten, R. A. V. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3086-2_14 · Cited by 21
Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia
de Klein, A. (1987) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(87)90029-7 · Cited by 21
Self-citationChen, C., Crutcher, E., Gill, H., Nelson, T. N., Robak, L. A., Jongmans, M. C. J., Pfundt, R., Prasad, C., Berard, R. A., Fannemel, M., et al. (2020) · Human Mutation · doi:10.1002/humu.24075 · Cited by 20
“Proto‐oncogene ABL1 is well known for being part of the fusion gene BCR‐ABL1 in the Philadelphia chromosome of leukemic cells (de Klein et al., 1982).”
BackgroundLocalization of an epithelial-specific receptor kinase (EDDR1) to chromosome 6q16
Shelling, A. N., Butler, R. J., Jones, T. A., Laval, S. H., Boyle, J. M., & Ganesan, T. S. (1995) · Genomics · doi:10.1016/0888-7543(95)80065-t · Cited by 20
The Abl/bcr Fusion Gene on Chromosome 9 in Ph-Negative Chronic Myelogenous Leukemia
Hsu, W.-T., Preisler, H. D., Szego, K., Sprudzs, R. M., & Gao, X.-Z. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00430-5 · Cited by 20
Application of Cytogenetics in Neoplastic Diseases
Sandberg, A. A., & Trent, J. M. (1985) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368509165844 · Cited by 20
Moley, J. F., Lairmore, T. C., & Phay, J. E. (1999) · Current Problems in Surgery · doi:10.1016/s0011-3840(99)80001-x · Cited by 20
Spurr, N. K., Gough, A. C., Goodfellow, P. J., Goodfellow, P. N., Lee, M. G., & Nurse, P. (1988) · Human Genetics · doi:10.1007/bf00291730 · Cited by 20
Self-citationZeng, F., Peng, Y., Qin, Y., Wang, J., Jiang, G., Feng, W., & Yuan, Y. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-01021-z · Cited by 19
“Discussion Bcr-Abl fusion gene drives the onset and development of CML, whereas the oncoprotein BCR-ABL with increased tyrosine kinase activity serves as a target for TKI treatment [33, 34].”
BackgroundNUAK2: an emerging acral melanoma oncogene
Namiki, T., Coelho, S. G., & Hearing, V. J. (2011) · Oncotarget · doi:10.18632/oncotarget.325 · Cited by 23
Zhelyazkova, A., Tonchev, A. B., Kolova, P., Ivanova, L. V., & Gercheva, L. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701854991 · Cited by 19
“a balanced translocation between chromosomes 9 and 22 [1,2].”
BackgroundStetka, J., Gurský, J., Velasquez, J. L., Mojzíková, R., Vyhlidalova, P., Vráblová, L., Bártek, J., & Divoký, V. (2020) · Cancers · doi:10.3390/cancers12040903 · Cited by 19
“Chronic myeloid leukemia (CML), a Philadelphia chromosome-positive (Ph+) chronic MPN, is characterized by the presence of BCR-ABL oncogene [1].”
BackgroundFlow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
Löf, L., Arngården, L., Olsson‐Strömberg, U., Siart, B., Jansson, M., Dahlin, J. S., Thörn, I., Christiansson, L. H., Hermansson, M., Larsson, A. O., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00755-y · Cited by 19
Hussein, K., Bock, O., & Kreipe, H. H. (2007) · Pathobiology · doi:10.1159/000099120 · Cited by 19
“In a considerable proportion of cases, clear-cut differentiation of ET from prefibrotic CIMF may be very difficult even for experienced bone marrow histopathologists. Furthermore, prefibrotic CIMF cases exhibit tremendous variability with regard to the duration of the stable phase before progression to fibrosis occurs…”
BackgroundMeyerson, M. M. (2007) · Nature · doi:10.1038/448545a · Cited by 19
Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia
Schwartz, J. J., Pinilla-Ibarz, J. A., Yuan, R., & Scheinberg, D. A. (2003) · Seminars in Hematology · doi:10.1016/s0037-1963(03)70046-8 · Cited by 19
Stability of Microsatellites in Myeloid Neoplasias
Boyer, J. C., Risinger, J. I., & Farber, R. A. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00043-0 · Cited by 19
Collins, S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112726 · Cited by 19
Hirosawa, S., Aoki, N., Matsushime, H., & Shibuya, M. (1988) · American Journal of Hematology · doi:10.1002/ajh.2830280107 · Cited by 19
Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter
Dumanski, J. P., van Kessel, A. H. M. G., Ruttledge, M. H., Wladis, A., Sugawa, N., Collins, V. P., & Nordenskjöld, M. (1990) · Human Genetics · doi:10.1007/bf00200562 · Cited by 19
Self-citationSz, H., Rodgers, G. P., Zeng, F., Zeng, Y., & Schechter, A. N. (1991) · Blood · doi:10.1182/blood.v78.9.2433.2433 · Cited by 19
Current Status of the BCR Gene and Its Involvement with Human Leukemia
Campbell, M. L., & Arlinghaus, R. B. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)61000-3 · Cited by 19
Ribera, J., Prawitz, T., Freitag, A. P., Sharma, A., Dobi, B., Rizzo, F., Sabatelli, L., & Patos, P. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02497-y · Cited by 18
Chromosomes in Leukemia and Beyond: From Irrelevant to Central Players
Rowley, J. D. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150144 · Cited by 20
“Moreover, using somatic cell hybrids, containing only the Ph chromosome (the 22q- chromosome) from the t(9;22), the Bootsma group in the Netherlands (7) showed that ABL was present in the hybrid cells and, therefore, part of chromosome 9 was on the Ph chromosome.”
MethodAlshalalfa, M., Bismar, T. A., & Alhajj, R. (2012) · Advances in Bioinformatics · doi:10.1155/2012/373506 · Cited by 18
“…pages, 2012. doi:10.1155/2012/373506 http://hdl.handle.net/1880/49199 journal article http://creativecommons.org/licenses/by/3.0/ Attribution 3.0 Unported Downloaded from PRISM: https://prism.ucalgary.ca Hindawi Publishing Corporation Advances in Bioinformatics Volume 2012, Article ID 373506, 13…”
MethodInfluentialMolecular pathogenesis of chronic myeloid leukaemia
Smith, D. L., Burthem, J., & Whetton, A. D. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403006835 · Cited by 22
Kancha, R. K., von Bubnoff, N. C. C., Miething, C., Peschel, C., Götze, K. S. S., & Duyster, J. (2008) · Haematologica · doi:10.3324/haematol.13207 · Cited by 18
“The product of Bcr-Abl is a cellular oncoprotein responsible for chronic myelogenous leukemia (CML) as well as Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).(2) Bcr-Abl is a constitutively active tyrosine kinase that induces a myriad of downstream signaling events resulting in clonal expansion of leukem…”
BackgroundNikitin, D. V., Tosato, V., Zavec, A. B., & Bruschi, C. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800464105 · Cited by 18
“In humans, translocation between chromosomes 9 and 22, t(9;22), producing the Philadelphia chromosome, causes myelogenous leukemia (1) because of the increased expression of the protooncogenic c-Abl tyrosine kinase gene, located at the translocation breakpoint (2).”
Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome—Refractory anemia with excess blasts
Fan, Y., Raza, A., Schumer, J. M., Sait, S. N. J., Block, A. W., Snyderman, M., & Sandberg, A. A. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90040-9 · Cited by 18
Complexity of an apparently simple variant Ph translocation in chronic myeloid leukemia
Morris, C. M., & Fitzgerald, P. H. (1987) · Leukemia Research · doi:10.1016/0145-2126(87)90022-1 · Cited by 18
Translocation of c-sis protooncogene in peripheral neuroepithelioma
Thiele, C. J., Whang‐Peng, J., Kao-Shan, C. S., Miser, J. S., & Israel, M. A. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90088-4 · Cited by 18
Francis, G. E., Michalevicz, R., & Wickremasinghe, R. G. (1983) · Leukemia Research · doi:10.1016/0145-2126(83)90076-0 · Cited by 18
Cytogenetic investigations of solid tumours of children.
Pearson, A. D. J., Reid, M. M., Davison, E. V., Bown, N. P., Malcolm, A. J., & Craft, A. W. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.9.1012 · Cited by 18
Proteins phosphorylated on tyrosine as markers of human tumor cell lines
Giordano, S., Renzo, M. F. D., Cirillo, D. M., Naldini, L., Chiado'-Piat, L., & Comoglio, P. M. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390413 · Cited by 18
de Oliveira, G. A. P., Pereira, E. G., Ferretti, G. D. S., Valente, A. P., Cordeiro, Y., & Silva, J. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500926 · Cited by 17
“c-Abl is directly involved in chronic myelogenous leukemia, a human malignancy genetically hallmarked by a reciprocal translocation between the bcr and c-abl genes (4, 5).”
BackgroundUmezawa, K., MASUOKA, S., Ohse, T., NAGANAWA, H., Kondo, S., IKEDA, Y., Kinoshita, N., HAMADA, M., SAWA, T., & TAKEUCHI, T. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.604 · Cited by 17
Giallongo, C., Cava, P. L., Tibullo, D., Barbagallo, I. A., Parrinello, N. L., Cupri, A., Stagno, F., Consoli, C., Chiarenza, A., Palumbo, G. A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-60 · Cited by 17
“CML is a myeloproliferative disease caused by the t (9;22) translocation [1] that generates BCR-ABL, a constitutively active tyrosine kinase (TK).”
BackgroundMultiple Endocrine Neoplasia Type 1
Thakker, R. V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00150-7 · Cited by 27
Gursky, S., Olopade, O. I., & Rowley, J. D. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00444-7 · Cited by 17
In situ hybridization: A valuable tool in diagnostic pathology
Denijn, M., Schuurman, H., Jacobse, K., & de Weger, R. A. (1992) · Apmis · doi:10.1111/j.1699-0463.1992.tb03984.x · Cited by 17
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.